Fieldpoint Private Securities’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-105
| Closed | -$16K | – | 1672 |
|
|
2021
Q1 | $16K | Hold |
105
| – | – | ﹤0.01% | 865 |
|
|
2020
Q4 | $16K | Buy |
+105
| New | +$16K | ﹤0.01% | 766 |
|
|
2020
Q1 | – | Sell |
-1,096
| Closed | -$119K | – | 617 |
|
|
2019
Q4 | $119K | Sell |
1,096
-198
| -15% | -$21.5K | 0.03% | 317 |
|
|
2019
Q3 | $127K | Sell |
1,294
-70
| -5% | -$6.87K | 0.05% | 254 |
|
|
2019
Q2 | $179K | Hold |
1,364
| – | – | 0.06% | 241 |
|
|
2019
Q1 | $184K | Buy |
1,364
+88
| +7% | +$11.9K | 0.08% | 201 |
|
|
2018
Q4 | $124K | Sell |
1,276
-1,180
| -48% | -$115K | 0.06% | 224 |
|
|
2018
Q3 | $341K | Hold |
2,456
| – | – | 0.13% | 160 |
|
|
2018
Q2 | $305K | Buy |
2,456
+70
| +3% | +$8.69K | 0.12% | 169 |
|
|
2018
Q1 | $266K | Hold |
2,386
| – | – | 0.12% | 147 |
|
|
2017
Q4 | $285K | Buy |
2,386
+594
| +33% | +$71K | 0.15% | 138 |
|
|
2017
Q3 | $251K | Buy |
1,792
+1,122
| +167% | +$157K | 0.11% | 172 |
|
|
2017
Q2 | $82K | Buy |
+670
| New | +$82K | 0.06% | 99 |
|